The Japanese Pharmaceutical Industry

The Japanese Pharmaceutical Industry

Author: Maki Umemura

Publisher: Taylor & Francis

Published: 2011-03-02

Total Pages: 209

ISBN-13: 1136828257

DOWNLOAD EBOOK

Charting the development of the industry from post-war devastation, through good recovery in the 1960s, and then up to the present, the book explores why Japan, despite being a world leader in many high technology industries, is only a minor player in the global pharmaceutical industry.


Advanced Materials in Japan

Advanced Materials in Japan

Author: COMLINE International COMLINE International Corp.

Publisher: Elsevier

Published: 2013-10-22

Total Pages: 478

ISBN-13: 1483294021

DOWNLOAD EBOOK

Please note this is a Short Discount publication. Advanced Materials in Japan: Source Book 1992 offers the reader news of all the developments which have taken place over the last year. The Source Book is divided into chapters based on the divisions of news in New Materials in Japan – Metals & Alloys; Ceramics; Composites; Electronic & Optoelectronic Materials; Magnetic Materials; Plastics; Materials & The Environment; Medical Materials and Textiles, each introduced by an expert in these particular areas and discussing the implications of the information to non–Japanese industry. In addition, the Source Book includes a chapter devoted to business/market information – company mergers acquisitions etc., together with an overview of the Japanese approach to advanced materials and highlighting all major research initiatives, research programmes etc.


Plunkett's Biotech & Genetics Industry Almanac

Plunkett's Biotech & Genetics Industry Almanac

Author: Jack W. Plunkett

Publisher: Plunkett Research, Ltd.

Published: 2008-09

Total Pages: 602

ISBN-13: 1593921241

DOWNLOAD EBOOK

A complete market research guide to the business of biotech, genetics, proteomics and related services--a tool for strategic planning, competitive intelligence, employment searches, or financial research. Complete profiles of nearly 400 leading biotech companies, in-depth chapters on trends. Includes glossary thorough indexes, statistics, research and development, emerging technology--as well a addresses, phone numbers, and executive names.


Fentanyl, Inc.

Fentanyl, Inc.

Author: Ben Westhoff

Publisher: Atlantic Monthly Press

Published: 2019-09-03

Total Pages: 365

ISBN-13: 080214795X

DOWNLOAD EBOOK

A four-year investigation into the world of synthetic drugs—from black market factories to users & dealers to harm reduction activists—and what it revealed. A deeply human story, Fentanyl, Inc. is the first deep-dive investigation of a hazardous and illicit industry that has created a worldwide epidemic, ravaging communities and overwhelming and confounding government agencies that are challenged to combat it. “A whole new crop of chemicals is radically changing the recreational drug landscape,” writes Ben Westhoff. “These are known as Novel Psychoactive Substances (NPS) and they include replacements for known drugs like heroin, cocaine, ecstasy, and marijuana. They are synthetic, made in a laboratory, and are much more potent than traditional drugs” —and all-too-often tragically lethal. Drugs like fentanyl, K2, and Spice—and those with arcane acronyms like 25i-NBOMe—were all originally conceived in legitimate laboratories for proper scientific and medicinal purposes. Their formulas were then hijacked and manufactured by rogue chemists, largely in China, who change their molecular structures to stay ahead of the law, making the drugs’ effects impossible to predict. Westhoff has infiltrated this shadowy world. He tracks down the little-known scientists who invented these drugs and inadvertently killed thousands, as well as a mysterious drug baron who turned the law upside down in his home country of New Zealand. Westhoff visits the shady factories in China from which these drugs emanate, providing startling and original reporting on how China’s vast chemical industry operates, and how the Chinese government subsidizes it. Poignantly, he chronicles the lives of addicted users and dealers, families of victims, law enforcement officers, and underground drug awareness organizers in the United States and Europe. Together they represent the shocking and riveting full anatomy of a calamity we are just beginning to understand. From its depths, as Westhoff relates, are emerging new strategies that may provide essential long-term solutions to the drug crisis that has affected so many. “Timely and agonizing. . . . An impressive work of investigative journalism.” —USA Today “Westhoff explores the many-tentacled world of illicit opioids, from the streets of East St. Louis to Chinese pharmaceutical companies, from music festivals deep in the Michigan woods to sanctioned ‘shooting up rooms’ in Barcelona, in this frank, insightful, and occasionally searing exposé. . . . Westhoff’s well-reported and researched work will likely open eyes, slow knee-jerk responses, and start much needed conversations.” —Publishers Weekly “Our 25 Favorite Books of 2019” —St. Louis Post-Dispatch “Best Books of 2019” —Buzzfeed “Best Nonfiction of 2019” —Kirkus Reviews “50 Best Books of 2019” —Daily Telegraph “Best Nonfiction Books of 2019” —Tyler Cowen “Best Books of 2019” —Yahoo Finance


Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry

Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry

Author: Mithun Nandy

Publisher: Springer Nature

Published: 2021-12-03

Total Pages: 224

ISBN-13: 981166921X

DOWNLOAD EBOOK

The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.